Investigating the Diagnostic Performance of High-resolution Specimen PET-CT in Determining Margin Status in Cancer Resection

NARecruitingINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

September 20, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Prostate Cancer SurgeryHead and Neck Cancers
Interventions
PROCEDURE

XEOS AURA 10 specimen PET-CT scan of tumour specimens

Participants will be injected with a small amount of radioactive tracer at the beginning of their cancer operation. This tracer will attach itself to the cancer cells. Once the surgical specimen is removed it will be placed into the specimen PET-CT scanner so that the surgeon can see the cancer within the specimen and assess the margin.

Trial Locations (1)

CV2 2DX

RECRUITING

University Hospitals Coventry and Warwickshire NHS Trust, Coventry

All Listed Sponsors
lead

University Hospitals Coventry and Warwickshire NHS Trust

OTHER

NCT06676943 - Investigating the Diagnostic Performance of High-resolution Specimen PET-CT in Determining Margin Status in Cancer Resection | Biotech Hunter | Biotech Hunter